Showing results (391-400 of 402) with videos related to
Sort By:
Pageof 41
Global Health, Epidemiology and Genomics|December 26, 2017
H3Africa multi-centre study of the prevalence and environmental and genetic determinants of type 2 diabetes in sub-Saharan Africa: study protocolK Ekoru, E H Young, C Adebamowo, et al.Diabetes Care|May 23, 2018
Aspects of Multicomponent Integrated Care Promote Sustained Improvement in Surrogate Clinical Outcomes: A Systematic Review and Meta-analysisLee Ling Lim, Eric S H Lau, Alice P S Kong, et al.Global Health, Epidemiology and Genomics|June 6, 2018
The need for an integrated approach for chronic disease research and care in AfricaA L Barr, E H Young, L Smeeth, et al.The Lancet. Healthy Longevity|December 15, 2022
Association of the triglyceride glucose index as a measure of insulin resistance with mortality and cardiovascular disease in populations from five continents (PURE study): a prospective cohort studyPatricio Lopez-Jaramillo, Diego Gomez-Arbelaez, Daniel Martinez-Bello, et al.The Lancet. Diabetes & Endocrinology|October 12, 2016
Diabetes diagnosis and care in sub-Saharan Africa: pooled analysis of individual data from 12 countriesJennifer Manne-Goehler, Rifat Atun, Andrew Stokes, et al.Plos One|June 3, 2014
The HIVToolbox 2 web system integrates sequence, structure, function and mutation analysisDavid P Sargeant, Sandeep Deverasetty, Christy L Strong, et al.Global Health, Epidemiology and Genomics|June 9, 2018
HIV treatment is associated with a two-fold higher probability of raised triglycerides: Pooled Analyses in 21 023 individuals in sub-Saharan AfricaKenneth Ekoru, Elizabeth H Young, David G Dillon, et al.International Journal of Epidemiology|January 14, 2014
Association of HIV and ART with cardiometabolic traits in sub-Saharan Africa: a systematic review and meta-analysisDavid G Dillon, Deepti Gurdasani, Johanna Riha, et al.The New England Journal of Medicine|March 16, 2010
Effect of valsartan on the incidence of diabetes and cardiovascular events, John J McMurray, Rury R Holman, et al.The New England Journal of Medicine|March 16, 2010
Effect of nateglinide on the incidence of diabetes and cardiovascular events, Rury R Holman, Steven M Haffner, et al.Pageof 41